Viking Therapeutics, Inc.
VKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001607678
In the last 90 days, Viking Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 437 institutions reported holding it in 13F filings for Q2 2026, worth $2.96B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Viking Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +18 vs. Q3 2023
- Shares held
- 76.4M
- −730.5K (−0.9%) vs. Q3 2023
- Total value
- $1.42B
- +$568.2M (+66.5%) vs. Q3 2023
- New holders
- 48
- 61 more added
- Sold out
- 30
- 54 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 437 | $2.96B |
| Q1 2026 | 414 | $2.43B |
| Q4 2025 | 427 | $2.54B |
| Q3 2025 | 371 | $1.87B |
| Q2 2025 | 392 | $2.02B |
| Q1 2025 | 373 | $1.88B |
| Q4 2024 | 409 | $3.30B |
| Q3 2024 | 422 | $5.27B |
| Q2 2024 | 388 | $4.26B |
| Q1 2024 | 373 | $6.56B |
| Q4 2023 | 197 | $1.42B |
| Q3 2023 | 179 | $854.0M |
| Q2 2023 | 193 | $1.21B |
| Q1 2023 | 185 | $1.11B |
| Q4 2022 | 129 | $319.7M |
| Q3 2022 | 107 | $72.4M |
| Q2 2022 | 115 | $77.2M |
| Q1 2022 | 140 | $93.8M |
| Q4 2021 | 140 | $166.5M |
| Q3 2021 | 135 | $237.7M |
| Q2 2021 | 138 | $226.9M |
| Q1 2021 | 144 | $259.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Viking Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −310,000−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −259,400−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −214,339−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −92,219−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −84,147−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −76,360−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −53,900−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −38,184−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −16,388−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −13,396−100.0% | Sold out |
| Titleist Asset Management, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −11,657−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −11,048−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −10,825−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,628−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −10,276−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −8,700−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,495−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −1,445−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −286−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |